The Valley Desk

NCT01399372 · Interventional trial

Rituximab, Methotrexate, Vincristine Sulfate, Procarbazine Hydrochloride, and Cytarabine With or Without Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma

Overall registry status Completed

Phase 2

Conditions Chemotherapeutic Agent Toxicity, Cognitive/Functional Effects, Lymphoma, Neurotoxicity, Radiation Toxicity

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov